Search research articles
Contact Us
Filters
Showing results (391-400 of 453) with videos related to
Page
of 46
Sort By:
Clinical Proteomics
|
June 24, 2017
A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption
Regent Lee, Roman Fischer, Philip D Charles, et al.
Clinical Proteomics
|
October 7, 2016
Plasma degradome affected by variable storage of human blood
Maria Kaisar, Leon F A van Dullemen, Marie-Laëtitia Thézénas, et al.
Proteomics
|
November 10, 2018
UFLC-Derived CSF Extracellular Vesicle Origin and Proteome
Alexander G Thompson, Elizabeth Gray, Imre Mager, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2025
Deep Learning Derived Adipocyte Size Reveals Adipocyte Hypertrophy is under Genetic Control
Emil Jørsboe, Phil Kubitz, Julius Honecker, et al.
Hepatology (Baltimore, Md.)
|
October 4, 2021
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial
Eric J Lawitz, Diane E Shevell, Giridhar S Tirucherai, et al.
Frontiers in Chemistry
|
September 27, 2019
Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics
Adán Pinto-Fernández, Simon Davis, Abigail B Schofield, et al.
American Journal of Human Genetics
|
September 5, 2025
Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution
Nikolas A Baya, Ilknur Sur Erdem, Samvida S Venkatesh, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution
Nikolas A Baya, Ilknur Sur Erdem, Samvida S Venkatesh, et al.
Elife
|
July 3, 2020
Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling
Emma J Fenech, Federica Lari, Philip D Charles, et al.
Lancet (London, England)
|
December 18, 2018
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal, Edgar D Charles, Brent A Neuschwander-Tetri, et al.
Page
of 46
Search research articles
Search
Showing results (391-400 of 453) with videos related to
Sort By:
Page
of 46
Clinical Proteomics
|
June 24, 2017
A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption
Regent Lee, Roman Fischer, Philip D Charles, et al.
Clinical Proteomics
|
October 7, 2016
Plasma degradome affected by variable storage of human blood
Maria Kaisar, Leon F A van Dullemen, Marie-Laëtitia Thézénas, et al.
Proteomics
|
November 10, 2018
UFLC-Derived CSF Extracellular Vesicle Origin and Proteome
Alexander G Thompson, Elizabeth Gray, Imre Mager, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2025
Deep Learning Derived Adipocyte Size Reveals Adipocyte Hypertrophy is under Genetic Control
Emil Jørsboe, Phil Kubitz, Julius Honecker, et al.
Hepatology (Baltimore, Md.)
|
October 4, 2021
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial
Eric J Lawitz, Diane E Shevell, Giridhar S Tirucherai, et al.
Frontiers in Chemistry
|
September 27, 2019
Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics
Adán Pinto-Fernández, Simon Davis, Abigail B Schofield, et al.
American Journal of Human Genetics
|
September 5, 2025
Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution
Nikolas A Baya, Ilknur Sur Erdem, Samvida S Venkatesh, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution
Nikolas A Baya, Ilknur Sur Erdem, Samvida S Venkatesh, et al.
Elife
|
July 3, 2020
Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling
Emma J Fenech, Federica Lari, Philip D Charles, et al.
Lancet (London, England)
|
December 18, 2018
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal, Edgar D Charles, Brent A Neuschwander-Tetri, et al.
Page
of 46